Breaking News

AGC Biologics Expands Cell and Gene Facility in Italy

Plans call for increased capacities and viral vector suspension capabilities at Milan site.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

AGC Biologics, a global biopharmaceutical contract development and manufacturing organization (CDMO), unveiled plans for the expansion of their Cell and Gene Therapy Center of Excellence in Milan, Italy to increase capacities and implement viral vector suspension capabilities. With this expansion, AGC Biologics will add two additional floors to the suite and install additional equipment on the current floor. The new facilities are scheduled to begin full operation in 2022. “I’m ver...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters